Capital Stock Repurchase Plan Transactions

9 Months Ended

Sep. 30, 2022

Capital Stock Repurchase Plan Transactions [Abstract]

Capital Stock Repurchase Plan Transactions

15.    Capital Stock Repurchase Plan Transactions

We repurchased the following capital stock:

	Three months ended September 30,				Nine months ended September 30,
	2022		2021		2022		2021
Total cost of repurchased shares (in thousands)	$	23,884	$	163,731	$	101,098	$	330,380
Shares repurchased		50,000		350,000		207,500		700,000
Weighted average price per share	$	477.68	$	467.80	$	487.22	$	471.97

In May and November 2021, the Board of Directors authorized a total of $600.0 million for additional stock repurchase under Chemed’s existing share repurchase program. We currently have $100.8 million of authorization remaining under this share repurchase plan.

‎